An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases

The critical role of IgE in allergic diseases is well-documented and clinically proven. Omalizumab, a humanized anti-IgE antibody, was the first approved antibody for the treatment of allergic diseases. Nevertheless, omalizumab still has some limitations, such as product instability and dosage restr...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Peipei, Pan, Zhongzong, Gu, Chunyin, Cao, Xiaodan, Liu, Xiaowu, Zhang, Jianjian, Xiao, Zheng, Wang, Xueping, Guo, Haibing, Ju, Dianwen, Deng, Su-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728613/
https://www.ncbi.nlm.nih.gov/pubmed/33329588
http://dx.doi.org/10.3389/fimmu.2020.596908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728613/
https://www.ncbi.nlm.nih.gov/pubmed/33329588
http://dx.doi.org/10.3389/fimmu.2020.596908

Ejemplares similares